{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T04:22:47Z","timestamp":1775535767834,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007051","name":"Uppsala University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Lyme neuroborreliosis (LNB) is a tick-borne infection caused by the spirochete<jats:italic>Borrelia burgdorferi<\/jats:italic>sensu lato complex with various neurological manifestations. The recommended treatment for LNB in Swedish children has been intravenous ceftriaxone 50\u2013100\u2009mg\/kg \u00d7\u20091 (&lt;\u20098\u2009years of age) or oral doxycycline 4\u2009mg\/kg \u00d7\u20091 (\u2265 8\u2009years of age) for 10\u201314\u2009days. Studies on adult LNB patients have shown equal efficacy for ceftriaxone and doxycycline, but no such studies have been conducted on pediatric LNB patients. The aim of this study is to retrospectively evaluate clinical outcome in children with LNB who have received intravenous ceftriaxone or oral doxycycline.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Clinical and laboratory data from three previously conducted prospective studies on children with LNB (1998\u20132014) were retrospectively analyzed. A total of 321 children (1\u201319\u2009years of age), who received antibiotic treatment for definite LNB or possible LNB, were included. Clinical outcome at the 2-month follow-up (recovery\/non-recovery) was evaluated using Chi<jats:sup>2<\/jats:sup>test and logistic multivariate regression analysis. Out of 321 LNB patients, 194 children (60%) had received ceftriaxone and 127 children (40%) had received doxycycline. When comparing clinical outcome between treatment groups, no difference was found (<jats:italic>p<\/jats:italic>\u2009=\u20090,217). Results did not change when incorporating relevant clinical and laboratory data into the logistic multivariate regression analysis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In this large retrospective study, no difference in clinical outcome was found, independent of age, when comparing children who received ceftriaxone with those who received doxycycline, supporting an equal effectiveness for treatment of LNB pediatric patients. However, future randomized comparative treatment studies are warranted for evaluation of efficacy of antibiotic treatment in pediatric LNB patients.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12887-022-03335-w","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T01:02:24Z","timestamp":1654736544000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Effectiveness of antibiotic treatment in children with Lyme neuroborreliosis - a retrospective study"],"prefix":"10.1186","volume":"22","author":[{"given":"Sigurdur","family":"Arnason","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbro H.","family":"Skogman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,9]]},"reference":[{"issue":"9814","key":"3335_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0140-6736(11)60103-7","volume":"379","author":"G Stanek","year":"2012","unstructured":"Stanek G, Wormser GP, Gray J, Strle F. Lyme borreliosis. Lancet. 2012;379(9814):461\u201373.","journal-title":"Lancet."},{"issue":"8","key":"3335_CR2","doi-asserted-by":"publisher","first-page":"2017","DOI":"10.3201\/eid2708.204763","volume":"27","author":"AR Marques","year":"2021","unstructured":"Marques AR, Strle F, Wormser GP. Comparison of Lyme disease in the United States and Europe. Emerg Infect Dis. 2021;27(8):2017\u201324.","journal-title":"Emerg Infect Dis"},{"key":"3335_CR3","doi-asserted-by":"publisher","first-page":"16090","DOI":"10.1038\/nrdp.2016.90","volume":"2","author":"AC Steere","year":"2016","unstructured":"Steere AC, Strle F, Wormser GP, Hu LT, Branda JA, Hovius JW, et al. Lyme borreliosis Nature reviews Disease primers. 2016;2:16090.","journal-title":"Lyme borreliosis Nature reviews Disease primers"},{"issue":"3","key":"3335_CR4","doi-asserted-by":"publisher","first-page":"101359","DOI":"10.1016\/j.ttbdis.2019.101359","volume":"11","author":"L Eisen","year":"2020","unstructured":"Eisen L. Vector competence studies with hard ticks and Borrelia burgdorferi sensu lato spirochetes: a review. Ticks and tick-borne diseases. 2020;11(3):101359.","journal-title":"Ticks and tick-borne diseases"},{"issue":"5","key":"3335_CR5","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1007\/s004150050216","volume":"245","author":"P Oschmann","year":"1998","unstructured":"Oschmann P, Dorndorf W, Hornig C, Schafer C, Wellensiek HJ, Pflughaupt KW. Stages and syndromes of neuroborreliosis. J Neurol. 1998;245(5):262\u201372.","journal-title":"J Neurol"},{"issue":"11","key":"3335_CR6","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1097\/INF.0000000000001653","volume":"36","author":"L Sodermark","year":"2017","unstructured":"Sodermark L, Sigurdsson V, Nas W, Wall P, Trollfors B. Neuroborreliosis in Swedish children: a population-based study on incidence and clinical characteristics. Pediatr Infect Dis J. 2017;36(11):1052\u20136.","journal-title":"Pediatr Infect Dis J"},{"issue":"12","key":"3335_CR7","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1097\/INF.0b013e31817fd423","volume":"27","author":"BH Skogman","year":"2008","unstructured":"Skogman BH, Croner S, Nordwall M, Eknefelt M, Ernerudh J, Forsberg P. Lyme neuroborreliosis in children: a prospective study of clinical features, prognosis, and outcome. Pediatr Infect Dis J. 2008;27(12):1089\u201394.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"3335_CR8","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1586\/eri.10.15","volume":"8","author":"D Tuerlinckx","year":"2010","unstructured":"Tuerlinckx D, Glupczynski Y. Lyme neuroborreliosis in children. Expert Rev Anti-Infect Ther. 2010;8(4):455\u201363.","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"11","key":"3335_CR9","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1136\/adc.2009.176529","volume":"95","author":"DM Broekhuijsen-van Henten","year":"2010","unstructured":"Broekhuijsen-van Henten DM, Braun KP, Wolfs TF. Clinical presentation of childhood neuroborreliosis; neurological examination may be normal. Arch Dis Child. 2010;95(11):910\u20134.","journal-title":"Arch Dis Child"},{"issue":"2","key":"3335_CR10","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1542\/peds.2011-3719","volume":"130","author":"BH Skogman","year":"2012","unstructured":"Skogman BH, Glimaker K, Nordwall M, Vrethem M, Odkvist L, Forsberg P. Long-term clinical outcome after Lyme neuroborreliosis in childhood. Pediatrics. 2012;130(2):262\u20139.","journal-title":"Pediatrics."},{"issue":"1","key":"3335_CR11","doi-asserted-by":"publisher","first-page":"8\u201316","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A, Ljostad U, Fingerle V, Rupprecht T, Schmutzhard E, Steiner I, et al. EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol. 2010;17(1):8\u201316\u2013e1\u20134.","journal-title":"Eur J Neurol"},{"issue":"5","key":"3335_CR12","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1016\/j.jpeds.2015.02.015","volume":"166","author":"SR Todd","year":"2015","unstructured":"Todd SR, Dahlgren FS, Traeger MS, Beltran-Aguilar ED, Marianos DW, Hamilton C, et al. No visible dental staining in children treated with doxycycline for suspected Rocky Mountain spotted fever. J Pediatr. 2015;166(5):1246\u201351.","journal-title":"J Pediatr"},{"issue":"10","key":"3335_CR13","doi-asserted-by":"publisher","first-page":"2887","DOI":"10.1093\/jac\/dkx245","volume":"72","author":"H Poyhonen","year":"2017","unstructured":"Poyhonen H, Nurmi M, Peltola V, Alaluusua S, Ruuskanen O, Lahdesmaki T. Dental staining after doxycycline use in children. J Antimicrob Chemother. 2017;72(10):2887\u201390.","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"3335_CR14","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1093\/jpids\/piy072","volume":"8","author":"SMC Lopez","year":"2019","unstructured":"Lopez SMC, Campfield BT, Nowalk AJ. Oral Management for Pediatric Lyme Meningitis. J Pediatric Infect Dis Soc. 2019;8(3):272\u20135.","journal-title":"J Pediatric Infect Dis Soc"},{"issue":"3","key":"3335_CR15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","volume":"15","author":"R Cross","year":"2016","unstructured":"Cross R, Ling C, Day NP, McGready R, Paris DH. Revisiting doxycycline in pregnancy and early childhood--time to rebuild its reputation? Expert Opin Drug Saf. 2016;15(3):367\u201382.","journal-title":"Expert Opin Drug Saf"},{"issue":"1","key":"3335_CR16","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/jac\/dky408","volume":"74","author":"J Karp","year":"2019","unstructured":"Karp J, Edman-Waller J, Toepfer M, Lundqvist A, Jacobsson G. Clostridioides difficile incidence related to in-hospital cephalosporin use: a tale of two highly comparable hospitals. J Antimicrob Chemother. 2019;74(1):182\u20139.","journal-title":"J Antimicrob Chemother"},{"issue":"8","key":"3335_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","volume":"7","author":"U Ljostad","year":"2008","unstructured":"Ljostad U, Skogvoll E, Eikeland R, Midgard R, Skarpaas T, Berg A, et al. Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol. 2008;7(8):690\u20135.","journal-title":"Lancet Neurol"},{"issue":"8","key":"3335_CR18","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1093\/cid\/ciaa217","volume":"72","author":"E Kortela","year":"2021","unstructured":"Kortela E, Kanerva MJ, Puustinen J, Hurme S, Airas L, Lauhio A, et al. Oral doxycycline compared to intravenous ceftriaxone in the treatment of Lyme Neuroborreliosis: a multicenter, equivalence, randomized. Open-label Trial Clin Infect Dis. 2021;72(8):1323\u201331.","journal-title":"Open-label Trial Clin Infect Dis"},{"issue":"1","key":"3335_CR19","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12883-016-0708-y","volume":"16","author":"R Dersch","year":"2016","unstructured":"Dersch R, Hottenrott T, Schmidt S, Sommer H, Huppertz HI, Rauer S, et al. Efficacy and safety of pharmacological treatments for Lyme neuroborreliosis in children: a systematic review. BMC Neurol. 2016;16(1):189.","journal-title":"BMC Neurol"},{"issue":"10","key":"3335_CR20","doi-asserted-by":"publisher","first-page":"1881","DOI":"10.1086\/382893","volume":"189","author":"M Widhe","year":"2004","unstructured":"Widhe M, Jarefors S, Ekerfelt C, Vrethem M, Bergstrom S, Forsberg P, et al. Borrelia-specific interferon-gamma and interleukin-4 secretion in cerebrospinal fluid and blood during Lyme borreliosis in humans: association with clinical outcome. J Infect Dis. 2004;189(10):1881\u201391.","journal-title":"J Infect Dis"},{"issue":"1","key":"3335_CR21","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1186\/s12887-018-1163-2","volume":"18","author":"K Backman","year":"2018","unstructured":"Backman K, Skogman BH. Occurrence of erythema migrans in children with Lyme neuroborreliosis and the association with clinical characteristics and outcome - a prospective cohort study. BMC Pediatr. 2018;18(1):189.","journal-title":"BMC Pediatr"},{"issue":"2","key":"3335_CR22","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1177\/019459988509300202","volume":"93","author":"JW House","year":"1985","unstructured":"House JW, Brackmann DE. Facial nerve grading system. Otolaryngol Head Neck Surg. 1985;93(2):146\u20137.","journal-title":"Otolaryngol Head Neck Surg"},{"key":"3335_CR23","first-page":"Doc03","volume":"18","author":"S Rauer","year":"2020","unstructured":"Rauer S, Kastenbauer S, Hofmann H, Fingerle V, Huppertz HI, Hunfeld KP, et al. Guidelines for diagnosis and treatment in neurology - Lyme neuroborreliosis. Ger. Med Sci. 2020;18:Doc03.","journal-title":"Med Sci"},{"issue":"12","key":"3335_CR24","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1097\/00006454-200212000-00011","volume":"21","author":"C Thorstrand","year":"2002","unstructured":"Thorstrand C, Belfrage E, Bennet R, Malmborg P, Eriksson M. Successful treatment of neuroborreliosis with ten day regimens. Pediatr Infect Dis J. 2002;21(12):1142\u20135.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"3335_CR25","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1212\/WNL.0000000000011151","volume":"96","author":"PM Lantos","year":"2021","unstructured":"Lantos PM, Rumbaugh J, Bockenstedt LK, Falck-Ytter YT, Aguero-Rosenfeld ME, Auwaerter PG, et al. Clinical practice guidelines by the Infectious Diseases Society of America, American Academy of Neurology, and American College of Rheumatology: 2020 guidelines for the prevention, diagnosis, and treatment of Lyme disease. Neurology. 2021;96(6):262\u201373.","journal-title":"Neurology."},{"key":"3335_CR26","doi-asserted-by":"crossref","unstructured":"Arnason S, Hultcrantz M, Nilsson A, Laestadius A. Peripheral facial nerve palsy in children in a Borrelia high-endemic area, a retrospective follow-up study. Acta Paediatr. 2019.","DOI":"10.1111\/apa.15063"},{"issue":"3\u20134","key":"3335_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.2119\/2007-00091.Rupprecht","volume":"14","author":"TA Rupprecht","year":"2008","unstructured":"Rupprecht TA, Koedel U, Fingerle V, Pfister HW. The pathogenesis of Lyme neuroborreliosis: from infection to inflammation. Mol Med. 2008;14(3\u20134):205\u201312.","journal-title":"Mol Med"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-022-03335-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-022-03335-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T21:24:52Z","timestamp":1700688292000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-022-03335-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,9]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["3335"],"URL":"https:\/\/doi.org\/10.1186\/s12887-022-03335-w","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,9]]},"assertion":[{"value":"3 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in this study involving human participants (children) were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. Approval of the study was obtained from the Regional Ethics Committee in Link\u00f6ping (Dnr 98103 and Dnr 02\u2013159) and Uppsala (Dnr 2010\/106), Sweden. Every child was assigned a specific study-ID. Written informed consent was received from parents\/guardians.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no financial or non-financial competing interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"332"}}